VPR Management’s Pfizer PFE Stock Holding History

VPR Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81K	Hold	100	–	–	﹤0.01%	65
2025 Q4	$2.49K	Buy	+100	New	+$2.52K	﹤0.01%	63

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

VPR Management's PFE Position: Q1 2026 in Review

VPR Management held its Pfizer (PFE) position steady in Q1 2026 at 100 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #65.

VPR Management first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

VPR Management held 100 shares of Pfizer worth $2.81K as of Q1 2026.
VPR Management left its Pfizer share count unchanged in Q1 2026.
Pfizer made up ﹤0.01% of VPR Management's portfolio in Q1 2026, its #65 holding.
VPR Management first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on VPR Management's 13F filing for Q1 2026, filed 15 May 2026.